Rybelsus revolutionizes diabetes management by introducing a novel oral medication that specifically targets Type 2 diabetes. This medication, a GLP-1 receptor agonist, offers patients a unique option, moving away from traditional insulin therapies and injectable medications. By stimulating insulin secretion and reducing appetite, Rybelsus plays a crucial role in aiding…